Synergistic efficacy of magnesium sulfate and FK506 on cerebral ischemia-induced infarct volume in gerbil

Medical Science Monitor

Volumn 10, Issue 4, 2004, Pages

  Chung, Shu Ying ^a,b   Lin, Jing Ying ^b   Lin, Ming Cheng ^b   Liu, Hui Ming ^c   Wang, Ming Fu ^a   Cheng, Fu Chou ^d  

^a PROVIDENCE UNIVERSITY   (Taiwan)

^b CHUNGTAI INST HLTH SCI TECHNOL   (Taiwan)

^c HUNGKUANG UNIVERSITY   (Taiwan)

^d TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Cerebral ischemia; Gerbil; Infarct volume; Magnesium sulfate

Indexed keywords

MAGNESIUM SULFATE; NEUROPROTECTIVE AGENT; TACROLIMUS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CADAVER; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENTIATION; GERBIL; IMAGING SYSTEM; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NONHUMAN; QUANTITATIVE ANALYSIS; STATISTICAL SIGNIFICANCE;

ANIMALS; CEREBELLUM; CEREBRAL INFARCTION; DRUG SYNERGISM; GERBILLINAE; IMMUNOSUPPRESSIVE AGENTS; MAGNESIUM SULFATE; MALE; TACROLIMUS;

EID: 1942470931     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Garraway WM, Whisnant JP, Furlan AJ et al: The declining incidence of stroke. N Engl J Med, 1979; 300: 449-52
2. Brott T, Broderick J, Kothari R et al: Tissue plasminogen activator for acute ischemic stroke. N Engl J Med, 1996; 333: 1581-87
3. Lee JM, Zipfel GJ, Chol DW: The changing landscape of ischemic brain injury mechanisms. Nature, 1999; 399: A7-14
4. Stelmasiak Z, Dudkowska-Konopa A, Rejdak K: Head trauma and neuroprotection. Med Sci Monit, 2000; 6: 426-32
5. Nagahiro S, Uno M, Sato K et al: Pathophysiology and treatment of cerebral ischemia. J Med Invest, 1998; 45: 57-70
6. Jean WC, Spellman SR, Nussbaum ES, Low WC: Reperfusion injury after focal cerebral ischemia: the role of inflammation and the therapeutic horizon. Neurosurg, 1998; 43: 1382-96
7. Ito U, Spatz M, Walker JT, Klatzo I: Experimental cerebral ischemia in Mongolian gerbils. Acta Neuropath, 1075; 32: 209-23
8. Cheng FC, Yang DY, Wu TF, Chen SH: Rapid on-line microdialysis hyphenated technique for the dynamic monitoring of extracellular pyruvate, lactic acid and ascorbic acid during cerebral ischemia. J Chromatogr B, 1999; 723: 31-38
9. Meyer FB, Jr Sundt TM, Yanagihara T, Anderson R: Focal cerebral ischemia: pathophysiologic mechanisms and rationale for future avenues of treatment. Mayo Clin Proc, 1987; 62: 35-55
10. Lipton SA, Rosenberg PA: Excitatory amino acids as a final common pathway for neurologic disorders. J Med, 1994; 330: 613-22
11. Altura BT, Memon ZI, Zhang A et al: Low levels of serum ionized magnesium are found in patients early after stroke which results in rapid elevation in cytosolic free calcium and spasm in cerebral vascular muscle cells. Neurosci Lett, 1997; 230: 37-40
12. Memon ZI, Altura BT, Benjamin JL et al: Predictive value of serum ionized but not total magnesium levels in head injuries. Scand J Clin Lab Invest, 1995; 55: 671-77
13. Iseri LT, French JH: Magnesium. Nature's physiologic calcium blocker. Am Heart J, 1984; 108: 188-94
14. Levko AV, Rakovich AA, Samoilenko SG, Konev SV: Characteristics of the hypoosmosis-induced calcium response in isolated nerve terminals of rat brain. Med Sci Monit, 2003; 9: 115-24
15. Nowak L, Bregestovski P, Ascher P et al: Magnesium gates glutamate-activated channels in mouse central neurons. Nature, 1984; 307: 462-65
16. Lampl Y, Gilad R, Geva D et al: Intravenous administration of magnesium sulfate in acute stroke: a randomized double-blind study. Clin Neurophamacol, 2001; 24: 11-5
17. Izumi Y, Roussel S, Pinard E, Seylaz J: Reduction of infarct volume by magnesium after middle cerebral artery occlusion in rats. J Cereb Blood Flow Metab, 1991; 11: 1025-30
18. Kaya M, Küçük M, Kalayci RB et al: Magnesium sulfate attenuates increased blood-brain barrier permeability during insulin-induced hypoglycemia in rats. Can J Physiol Pharmacol, 2001; 79: 793-98
19. Miles AN, Majda BT, Meloni BP, Knuckey NM: Postischemic intravenous administration of magnesium sulfate inhibits hippocampal CA1 neuronal death after transient global ischemia in rats. Neurosurg, 2001; 49: 1443-51
20. Yang Y, Li Q, Ahmad F, Shuaib A: Survival and histological evaluation of therapeutic window of post-ischemia treatment with magnesium suilfate in embolic stroke model of rat. Neurosci Lett, 2000; 285: 119-22
21. Şirin BH, Cotkun E, Yilik L et al: Neuroprotective effects of preischemia subcutaneous magnesium sulfate in transient cerebral ischemia. Europ J Cardio-thorac Surg, 1998; 14: 82-8
22. Marinov MB, Harbaugh KS, Hoopes PJ et al: Neuroprotective effects of preischemia intraarterial magnesium sulfate in reversible focal cerebral ischemia. J Neurosurg, 1996; 85: 117-24
23. Zoratti M, Szabò I: The mitochondrial permeability transition. Biochim Biophys Acta, 1995; 1241: 139-76
24. Sutoo D, Akiyama K: Opposite effects of calcium and magnesium on the central blood pressure regulation in the spontaneously hypertensive rats. Jpn J Pharmacol, 2001; 86: 366-68
25. Rasmussen HS, Larsen OG, Meier K, Larsen J: Hemodynamic effects of intravenously administered magnesium on patients with ischemic heart disease. Clin Cardiol, 1988; 11: 824-28
26. Nozaki H, Tanaka K, Shirai T et al: Binding capacity of FK506 binding protein after 2-hour hemispheric ischemia in gerbil brain. Brain Res, 1998; 781: 1-7
27. Liu J, Farmer JD Jr, Lane WS et al: Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell, 1991; 66: 807-15
28. Siesjo BK, Elmer E, Janelidze S et al: Role and mechanisms of secondary mitochondrial failure. Acta Neurochir Suppl, 1999; 73: 7-13
29. Butcher SP, Henshall DC, Teramura Y et al: Neuroprotective actions of FK506 in experimental stroke: in vivo evidence against an antiexcitotoxic mechanism. J Neurosci, 1997; 7: 6939-46
30. Kuroda S, Janelidze S, Siesjo Bo K: The immunosuppressants cyclosporin A and FK506 equally ameliorate brain damage due to 30-mm middle cerebral artery occlusion in hyperglycemic rats. Brain Res, 1999; 835: 148-53
31. Drake M, Friberg H, Boris-Moller F et al: The immunosuppressant FK506 ameliorates ischemic damage in the rat brain. Acta Physiol Scand, 1996; 158: 155-59
32. Aoyama S, Katayama Y, Terashi A: The effect of FK506, an immunosuppressant, on cerebral infarction volume in focal cerebral ischemia in rats. J Nippon Med Sch, 1997; 64: 416-21
33. Ebisu T, Matsuta K, Fujikawa A et al: Early and delayed neuroprotective effects of FK506 on experimental focal ischemia quantitatively assessed by diffusion-weighted MRI. Magnetic Resonance Imaging, 2001; 19: 153-60
34. Sharkey J, Butcher SP: Immunophilins mediate the neuroprotective effects of FK506 in focal cerebral ischemia. Nature, 1994; 371: 336-39
35. Baskaya MK, Dogan A, Dempsey RJ: Application of endovascular suture occlusion of middle cerebral artery in gerbils to obtain consistent infarction. Neurol Res, 1999; 21: 574-78
36. Yamamoto K, Akai F, Yoshimine T, Yanagihara T: Immunohistochemical investigation of cerebral ischemia after middle cerebral artery occlusion in gerbils. J Neurosurg, 1987; 67: 414-20
37. Yoshimine T, Yanagihara T: Regional cerebral ischemia by occlusion of the posterior communicating artery and the middle cerebral artery in gerbils. J Neurosurg, 1983; 58: 362-67
38. Bederson JB, Pitts LH, Germano SM et al: Evaluation of 2, 3, 5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats. Stroke, 1986; 17: 1304-8
39. 2+ administration up to twenty-four hours following reperfusion prevents ischemic damage of the CA1 neurons in the rat hippocampus. Neurosci, 1991; 44: 335-41
40. Bonfoco E, Krainc D, Ankarcrona M et al: Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures. Proc Natl Acad Sci USA, 1995; 92: 7162-66
41. Chi OZ, Pollak P, Weiss HR: Effects of magnesium sulfate and nifedipine on regional cerebral blood flow during middle cerebral artery ligation in the rat. Arch Int Pharmacodyn Ther, 1990; 304: 196-205
42. Muir KW: New experimental and clinical data on the efficacy of pharmacological magnesium infusions in cerebral infarcts. Magnesium Res, 1998; 11: 43-56
43. Freedman AM, Mak IT, Stafford RE et al: Erythrocytes from magnesium-deficient hamsters display an enhanced susceptibility to oxidative stress. Am J Physiol, 1992; 62: C1371-75
44. Rothman SM: Synaptic release of excitatory amino acid neurotransmitter mediates anoxic neuronal death. J Neurosci, 1984; 4: 1884-91
45. Rothman SM, Olney JW: Glutamate and the pathophysiology of hypoxic-ischemic brain damage. Ann Neurol, 1986; 19: 105-11